compounded glp-1 fda New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Intensifies Crackdown on GLP-1
Description
In doing so, we are saving money for employers, health plans, government entities, and the health systems that hire us.

CONSUMER LAW GROUP is investigating a Canada wide class action lawsuit against Novo Nordisk Canada Inc and Eli Lilly Canada Inc in relation to their weight l

Learn whether Mounjaro is safe after gallbladder removal
Our 2026 Virta Vitals report just dropped, and it turns out nearly 70% of current and former users prefer to keep it to themselves

My scrubs were painfully tight, and during one shift I nearly fainted from low blood sugar

The Trump administration announced agreements with Eli Lilly and Novo Nordisk to reduce the prices of the companies GLP-1 drugs.
